Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis.

McLaughlin KA, Chitnis T, Newcombe J, Franz B, Kennedy J, McArdel S, Kuhle J, Kappos L, Rostasy K, Pohl D, Gagne D, Ness JM, Tenembaum S, O'Connor KC, Viglietta V, Wong SJ, Tavakoli NP, de Seze J, Idrissova Z, Khoury SJ, Bar-Or A, Hafler DA, Banwell B, Wucherpfennig KW.

J Immunol. 2009 Sep 15;183(6):4067-76. doi: 10.4049/jimmunol.0801888. Epub 2009 Aug 17.

2.

Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.

Zhou D, Srivastava R, Nessler S, Grummel V, Sommer N, Brück W, Hartung HP, Stadelmann C, Hemmer B.

Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19057-62. Epub 2006 Dec 1.

3.

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

Lalive PH, Menge T, Delarasse C, Della Gaspera B, Pham-Dinh D, Villoslada P, von Büdingen HC, Genain CP.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2280-5. Epub 2006 Feb 3.

4.

Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.

O'Connor KC, Appel H, Bregoli L, Call ME, Catz I, Chan JA, Moore NH, Warren KG, Wong SJ, Hafler DA, Wucherpfennig KW.

J Immunol. 2005 Aug 1;175(3):1974-82.

5.

Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis.

Guggenmos J, Schubart AS, Ogg S, Andersson M, Olsson T, Mather IH, Linington C.

J Immunol. 2004 Jan 1;172(1):661-8.

6.

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.

Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CC, Ben-Nun A.

J Clin Invest. 1993 Dec;92(6):2602-8.

7.

The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?

Lee DH, Linker RA.

Expert Opin Ther Targets. 2012 May;16(5):451-62. doi: 10.1517/14728222.2012.677438. Epub 2012 Apr 12. Review.

PMID:
22494461
8.

Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis.

Kennel De March A, De Bouwerie M, Kolopp-Sarda MN, Faure GC, Béné MC, Bernard CC.

J Neuroimmunol. 2003 Feb;135(1-2):117-25.

PMID:
12576231
9.

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.

Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C.

Glia. 2001 Nov;36(2):220-34. Review.

PMID:
11596130
10.

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.

O'Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C, Robinson WH, Cherry SV, Bar-Or A, Banwell B, Fukaura H, Fukazawa T, Tenembaum S, Wong SJ, Tavakoli NP, Idrissova Z, Viglietta V, Rostasy K, Pohl D, Dale RC, Freedman M, Steinman L, Buckle GJ, Kuchroo VK, Hafler DA, Wucherpfennig KW.

Nat Med. 2007 Feb;13(2):211-7. Epub 2007 Jan 12.

11.

The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.

Haase CG, Guggenmos J, Brehm U, Andersson M, Olsson T, Reindl M, Schneidewind JM, Zettl UK, Heidenreich F, Berger T, Wekerle H, Hohlfeld R, Linington C.

J Neuroimmunol. 2001 Mar 1;114(1-2):220-5.

PMID:
11240035
12.

Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.

Raddassi K, Kent SC, Yang J, Bourcier K, Bradshaw EM, Seyfert-Margolis V, Nepom GT, Kwok WW, Hafler DA.

J Immunol. 2011 Jul 15;187(2):1039-46. doi: 10.4049/jimmunol.1001543. Epub 2011 Jun 8.

14.
15.

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Küker W, Chandratre S, Vincent A, Palace J.

JAMA Neurol. 2014 Mar;71(3):276-83. doi: 10.1001/jamaneurol.2013.5857.

PMID:
24425068
16.
18.

Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.

Mantegazza R, Cristaldini P, Bernasconi P, Baggi F, Pedotti R, Piccini I, Mascoli N, La Mantia L, Antozzi C, Simoncini O, Cornelio F, Milanese C.

Int Immunol. 2004 Apr;16(4):559-65.

PMID:
15039386
19.
20.

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.

Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M.

J Neuroinflammation. 2011 Dec 28;8:184. doi: 10.1186/1742-2094-8-184.

Supplemental Content

Support Center